A Comparison of Different Concentration Ropivacaine for Patient-controlled Epidural Analgesia

NCT03195309 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-06-22

No results posted yet for this study

Summary

To compare the postoperative analgesic effect and the intensity of motor block in different concentration ropivacaine plus fentanyl when used epidurally with a patient-controlled analgesia device after Cesarean delivery.

Conditions

  • Epidural Anesthesia
  • Cesarean Section

Interventions

DRUG

Ropivacaine

Compare different concentration of ropivacaine and fentanyl for elective Cesarean delivery post operative pain control.

DRUG

Fentanyl

Compare different concentration of ropivacaine and fentanyl for elective Cesarean delivery post operative pain control.

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • Hui-Fang Huang · Kaohsiung Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-20
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03195309 on ClinicalTrials.gov